Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact

Novo Nordisk has expanded its drug delivery collaboration with Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH). Building on advances such as the SOMA robotic pill, the partners will work on bioelectronics, biosensors and stimuli-responsive delivery devices.